01
You confirm the diagnosis
During the encounter, you review the ICD-10 suggestion Copergrine has drafted from the ambient scribe and confirm it. Nothing surfaces until you do. Your judgment is the trigger — not the model's.
Evidence-based care
Evidence-based plans, surfaced inside the encounter.
Copergrine reads your confirmed diagnosis, surfaces the relevant plan from a curated library of major medical societies, and lets you sign with one click.
We do not replace your judgment. We accelerate it.
How it surfaces
Three steps, in the flow of the encounter.
02
Copergrine reads your library
The platform queries a curated library of the current major society guidelines tagged to that diagnosis. For E11.65 (Type 2 diabetes, uncontrolled), that is ADA Standards of Care 2024 and AACE T2DM Algorithm 2022.
03
The plan appears inline, you edit and sign
First-line medications, monitoring schedule, red flags, and lifestyle interventions appear as a structured draft next to your note. You edit, add, or remove anything. Then you sign and lock. Nothing submits automatically.
The library
Eight major medical societies at launch.
Each library is curated by our clinical team and reviewed before it goes live. When a society publishes a material update, we review, validate, and push it.
ADA
American Diabetes Association
Type 1 and Type 2 diabetes, prediabetes, gestational diabetes, complications
Latest
Standards of Medical Care in Diabetes — 2024
AHA / ACC
American Heart Association / American College of Cardiology
Hypertension, cholesterol, heart failure, ASCVD prevention
Latest
2017 HTN (2022 update), 2018 Cholesterol, 2022 HFSA Heart Failure
AACE
American Association of Clinical Endocrinology
Obesity, thyroid, type 2 diabetes, dyslipidemia, osteoporosis
Latest
2022 Obesity Algorithm, 2022 T2DM Algorithm
USPSTF
U.S. Preventive Services Task Force
Screening, counseling, and preventive-medication recommendations
Latest
2024 recommendation statements (continuously updated)
IDSA
Infectious Diseases Society of America
Antibiotic stewardship, sepsis, HIV, UTI, pneumonia, cellulitis, COVID-19
Latest
IDSA practice guidelines (continuously updated)
AAFP
American Academy of Family Physicians
Family medicine, preventive care, chronic disease management
Latest
AAFP clinical recommendations (continuously updated)
ACOG
American College of Obstetricians and Gynecologists
Women's health, contraception, obstetrics, gynecology, menopause
Latest
ACOG Practice Bulletins (continuously updated)
AAP
American Academy of Pediatrics
Pediatric medicine, vaccination, developmental screening, adolescent health
Latest
Bright Futures, Red Book (continuously updated)
Sample plan
What a surfaced plan looks like.
This is the actual draft Copergrine surfaces when you confirm E11.65 — Type 2 Diabetes Mellitus, uncontrolled. Every line is editable.
Diagnosis
Type 2 Diabetes Mellitus, uncontrolled
ICD-10 · E11.65
Source
ADA Standards of Medical Care in Diabetes — 2024
Cross-referenced with AACE T2DM 2022
First-line medications
- Metformin500 mg PO BID, titrate to 1000 mg BID over 2–4 weeks as tolerated (hold if eGFR < 30)
- Add GLP-1 agonist (semaglutide 0.25 mg → 1.0 mg SQ weekly) or SGLT2 inhibitor(empagliflozin 10–25 mg PO daily) if HbA1c > 9% or ASCVD/HF/CKD present
Monitoring schedule
- HbA1c every 3 months until goal < 7%, then every 6 months
- BMP + urine albumin/creatinine ratio every 6 months (kidney function)
- Lipid panel annually; LDL goal < 70 mg/dL if ASCVD
- Annual dilated eye exam and monofilament foot exam each visit
Red flags — escalate or refer
- Random glucose > 300 mg/dL with symptoms, or positive ketones → ED
- Unexplained weight loss, fatigue, polyuria despite therapy → endocrinology referral
- Recurrent cellulitis, non-healing ulcers, or neuropathy progression → wound care / podiatry
Lifestyle interventions
- Medical nutrition therapy referral; carbohydrate counting or plate method
- 150 min/week moderate-intensity aerobic activity + 2 sessions resistance training
- Weight-loss goal of 5–10% of baseline body weight for patients with BMI > 25
Curated by clinicians
Reviewed quarterly. Updated on material change.
Each guideline library is maintained by our clinical team — physicians and nurse practitioners who practice on the platform every day. We review the core libraries (ADA, AHA/ACC, AACE, USPSTF) every quarter, and we push updates whenever a society publishes a material change.
You see the guideline version and the last-reviewed date next to every surfaced plan. No silent drift between versions.
Disclaimer
This is decision support, not decision replacement.
Copergrine surfaces evidence-based plans to accelerate documentation and reduce cognitive load. It does not diagnose patients, does not prescribe, does not submit claims, and does not sign notes. A licensed clinician reviews, edits, and signs every encounter.
Copergrine is not a substitute for clinical judgment. If a surfaced plan does not match the patient in front of you, override it. The platform logs every edit so your reasoning is auditable later.
Frequently asked questions
- Does the evidence-based plan replace my clinical judgment?
- No. The plan is a structured draft drawn from the current major society guidelines. Every line is editable, and nothing is submitted or locked until you review and sign. Copergrine surfaces the guideline, you decide how it applies to this patient.
- Which society guidelines does Copergrine pull from?
- ADA, AHA/ACC, AACE, USPSTF, IDSA, AAFP, ACOG, and AAP at launch. More are added as we validate them with our clinical team. If your specialty is not represented, tell us — we add libraries based on provider demand.
- How often is the library refreshed?
- Quarterly for the core libraries (ADA, AHA/ACC, AACE, USPSTF) and whenever a society publishes a material update. Our clinical team reviews every change before it goes live, so you do not see guideline drift between versions without knowing about it.
- Is this a CDS tool under FDA rules?
- Copergrine operates as a Clinical Decision Support tool that meets the 21st Century Cures Act exemption criteria: it is transparent about its sources, it shows you why each suggestion was made, and it does not automate clinical decisions. A licensed clinician reviews and signs every plan.
- Can I turn off the evidence-based plan surfacing?
- Yes. Any clinician can disable EBP surfacing for their own account, or disable it for a specific diagnosis. Some providers prefer to draft from scratch and use the guidelines only as a post-hoc review; the platform supports both workflows.
Pricing
$229 / provider / month
Everything included. Up to 10 providers. No add-ons.
See full pricing →